Ticker	Volume	Price	Price Delta
DJIA	15,354.40	+121.18	0.80%
S&P 500	1,667.47	+17.00	1.03%
Nasdaq	3,498.97	+33.72	0.97%

Ticker

Volume

Price

Price Delta

DJIA

15,354.40

+121.18

0.80%

S&P 500

1,667.47

+17.00

1.03%

Nasdaq

3,498.97

+33.72

0.97%

Ticker	Volume	Price	Price Delta
STOXX 50	2,817.99	+11.29	0.40%
FTSE 100	6,723.06	+35.26	0.53%
DAX	8,398.00	+28.13	0.34%

Ticker

Volume

Price

Price Delta

STOXX 50

2,817.99

+11.29

0.40%

FTSE 100

6,723.06

+35.26

0.53%

DAX

8,398.00

+28.13

0.34%

Ticker	Volume	Price	Price Delta
Nikkei	15,345.80	+207.69	1.37%
Hang Seng	23,478.50	+395.81	1.71%
S&P/ASX 200	5,219.20	+38.43	0.74%

Ticker

Volume

Price

Price Delta

Nikkei

15,345.80

+207.69

1.37%

Hang Seng

23,478.50

+395.81

1.71%

S&P/ASX 200

5,219.20

+38.43

0.74%

Reckitt Benckiser to Stop Selling Suboxone Tablets

By Matthew Boyle - 2012-09-25T07:13:49Z

Reckitt Benckiser Group Plc (RB/) will cease production of the Suboxone opioid-dependency drug in tablet form, a person familiar with the decision said today.

The person, who declined to be named, said an announcement from the company will be made later today.

To contact the reporter on this story: Matthew Boyle in London at mboyle20@bloomberg.net

To contact the editor responsible for this story: Sara Marley at smarley1@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.